The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular...
The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues
About this item
Full title
Author / Creator
Pang, Yu‐Yan , Li, Jian‐Di , Gao, Li , Yang, Xia , Dang, Yi‐Wu , Lai, Ze‐Feng , Liu, Li‐Min , Yang, Jie , Wu, Hua‐Yu , He, Rong‐Quan , Huang, Zhi‐Guang , Xiong, Dan‐Dan , Yang, Li‐Hua , Shi, Lin , Mo, Wei‐Jia , Tang, Deng , Lu, Hui‐Ping and Chen, Gang
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Hepatocellular carcinoma (HCC) remains one of the most common cancers worldwide and tends to be detected at an advanced stage. More effective biomarkers for HCC screening and prognosis assessment are needed and the mechanisms of HCC require further exploration. The role of MAOA in HCC has not been intensively investigated.
Methods<...
Alternative Titles
Full title
The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_74c35f00e731403fbcc2be0018279d9c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_74c35f00e731403fbcc2be0018279d9c
Other Identifiers
ISSN
2045-7634
E-ISSN
2045-7634
DOI
10.1002/cam4.3434
